Holen Sie sich die Stockscreener-App
38.97
2.38%
-0.97
Schlusskurs vom Vortag:
$39.94
Offen:
$39.32
24-Stunden-Volumen:
79,667
Relative Volume:
0.12
Marktkapitalisierung:
$699.56M
Einnahmen:
$116.88M
Nettoeinkommen (Verlust:
$-25.09M
KGV:
-278.36
EPS:
-0.14
Netto-Cashflow:
$-20.74M
1W Leistung:
+7.95%
1M Leistung:
+45.32%
6M Leistung:
+113.18%
1J Leistung:
+42.25%
1-Tages-Spanne:
$38.58
$39.67
1-Wochen-Bereich:
$34.00
$40.06
52-Wochen-Spanne:
$14.63
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Firmenname
Rigel Pharmaceuticals
Sektor
Branche
Telefon
650-624-1100
Adresse
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RIGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
39.00 | 724.96M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.30 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.12 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.76 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.04 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
372.49 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-05 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-06-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Eingeleitet | B. Riley Securities | Neutral |
| 2020-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Fortgesetzt | JP Morgan | Overweight |
| 2019-03-01 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Eingeleitet | Citigroup | Buy |
| 2018-05-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-31 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-30 | Bestätigt | Piper Jaffray | Overweight |
| 2016-07-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-04-22 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Bestätigt | Stifel | Buy |
| 2012-11-29 | Eingeleitet | UBS | Neutral |
| 2012-11-06 | Bestätigt | Oppenheimer | Outperform |
| 2012-03-26 | Eingeleitet | Canaccord Genuity | Hold |
| 2010-12-10 | Herabstufung | MP Advisors | Outperform → Market Perform |
Alle ansehen
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
How Rigel Pharmaceuticals Inc. stock performs in high volatility marketsTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleJuly 2025 Recap & Community Verified Trade Signals - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock sustain dividend payoutsTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Applying big data sentiment scoring on Rigel Pharmaceuticals Inc.July 2025 Breakouts & Real-Time Volume Analysis - newser.com
How Rigel Pharmaceuticals Inc. stock responds to policy changesJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Can a trend reversal in Rigel Pharmaceuticals Inc. lead to recoveryJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Rigel (Nasdaq: RIGL) to present in London at Jefferies Healthcare Conference - Stock Titan
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st
Will earnings trigger a reversal in Rigel Pharmaceuticals Inc.2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Rigel Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Will Rigel Pharmaceuticals Inc. stock attract ESG investorsAnalyst Downgrade & Daily Price Action Insights - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidity2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Rigel Pharmaceuticals Inc Stock Analysis and ForecastMarket Profile Overview & Low Risk Capital Growth - earlytimes.in
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Short Interest & Real-Time Volume Triggers - newser.com
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targetsWeekly Gains Report & Entry Point Strategy Guides - newser.com
Detecting price anomalies in Rigel Pharmaceuticals Inc. with AIJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Candlestick signals on Rigel Pharmaceuticals Inc. stock todayInflation Watch & Weekly Momentum Stock Picks - newser.com
Trading Systems Reacting to (RIGL) Volatility - news.stocktradersdaily.com
Can Rigel Pharmaceuticals Inc. stock hit analyst price targetsPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
What momentum shifts mean for Rigel Pharmaceuticals Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-11-09 21:25:18 - newser.com
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook - Yahoo Finance
Measuring Rigel Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Published on: 2025-11-09 05:40:52 - newser.com
Published on: 2025-11-09 04:34:19 - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proof2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - simplywall.st
Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):